Palliative Pharmacotherapy for End-Stage Cardiovascular Diseases

All sessions are listed in Central Time (CT). 

Symposia

  • Date:
  • Time: -
  • Track: Clinical Practice
  • CME/CE: 1.0

Sponsored by the Cardiovascular Diseases and Aging SIG

Patients with end-stage cardiovascular diseases commonly experience suboptimal treatment outcomes, high therapeutic burden, and poor quality of life. Palliative approaches for end-stage cardiovascular diseases provide an alternative approach that often helps patients better achieve care they value. However, compared to other life-threatening diseases, palliative care is underutilized among older adults with end-stage cardiovascular diseases. Learning Objectives: (1) explain why palliative pharmacotherapy is critical in the care of end-stage cardiovascular diseases among older adults; (2) review necessary medications used for palliative care for end-stage cardiovascular diseases among older adults; (3) discuss the process of deprescribing cardiovascular medications for palliative care for end-stage cardiovascular diseases among older adults; (4) describe the value of pharmacists, geriatricians and cardiologists working together in the care for end-stage cardiovascular diseases among older adults.

Right Patient, Right Time: How and When to Initiate Palliative Pharmacotherapy 

Katherine E. Di Palo, PharmD, MBA, MS, FAHA, FHFSA

To Deprescribe or Not Deprescribe: That is the Question 

Parag Goyal, MD, MSc 

Aging Hearts and Healing Hands: Geriatricians in End-Stage Cardiovascular Diseases Care 

Min Ji Kwak, MD, MS, DrPH